Peter Thy is completely mistaken in Alzheimer’s disease

the New York Times Ran a Long interview This morning, the clerk of the column Ross Diatat, the founder of the investment capitalist and the founder of Paypal Peter Thil. There is a reason published in the opinion department.

Thil, Trump Supporter for whom Allies – Including Vice President JD Vance – It was now granted in the White House, a free era to discuss a variety of topics within more than an hour of soft football questions. Is Grega Thonberg Christ the Antichrist? Are the three ideological schools prevailing in the environment of Europe, “Islamic law” and “Chinese Communist Championship”? Is Amnesty International “woke up” and capable of following Elon Musk to Mars? Peter seems to think that! Perhaps the Press College may add “Just asking questions”Hey, what is the curse you are talking about“To its ammunition.

It is recognized that many of these assurances fall directly in the world of things that are in the palace of the mind instead of verified facts, with the exception of at least one. Relatively early in their conversation, Peter Ross tells the following (assuring us):

It is a very bold claim! It is also completely incorrect.

“There was no cure 40 or 50 years ago for Alzheimer’s disease,” Sterling Johnson, Professor of Agency and Ageology at the University of Wisconsin, Madison, told Engadget. “What we have been able to do over the past twenty years has been actually unusual. We have developed signs that help us determine when this disease begins, using amyloid signs and biological signs, we know that the disease actually begins 20 years before symptoms, and this is important to know if we will prevent this disease.”

Currently, Alzheimer’s disease is still curable. But the lack of a miracle treatment does not negate the achievements yet in detection and prevention. “The first treatments were these dressing treatments. It is like treating symptoms as if you were treating the cold (…) The first generation of amyloid was this type of approach where only symptoms were taken by increasing neurons and increasing neurons available to brain cells.” Johnson, whose team runs one of the largest and longer studies People at risk of developing Alzheimer’s disease have, “We now have opportunities to adjust the disease biology through the amyloid path, but we also focus on the other protein disease – which is Tao There are ongoing clinical experiences. “

Thiel, a well -known preacher to advance the extension of radical life (including a I mentioned Attention to injecting itself with the blood of youth) believes that the state of scientific research in this field is slow and risk. But pioneering work happens at this moment. Professor Johnson referred to a single -style anti -aid body Gantenerumab. In an early test of 73 participants with inherited mutations that will make them overlook the amyloid production in the brain, it reduces the number of participants who have practically developed symptoms of Alzheimer’s. “Prevention of the Great Third Phase (from Gantenerumab) is now speaking,”

For someone who displays himself as an uncomfortable thinker, Thiel seems to have definitely stumbled at a significantly similar point of discussion to the current Trump administration head, Robert F Kennedy JR. He said In a hearing in the Ministry of Health last month. He claimed that the national health institutes were “cutting any other hypothesis” because of “corruption”.

It is not surprising, Al -Zheimer’s Association described this “clearly false”.

In fact, over the ten years available (2014-2023), Less than 14 % One of the new National Institutes of Health (NIH) is Alzheimer’s new, which focused on experimenting with amyloid as a therapeutic goal. books“As of September 2024, National Institute of Agency He was investing in 495 drug and non -drug experiments. It is mentioned that Alzheimer’s research focuses on the amyloid to exclude other goals that is clear. “

If you personally, you wanted more powerful medical research and an eternal life opportunity (no), which led to the widespread lubrication of management wheels Funding financing for science It will be a strange way to achieve this. But this is a kind of inconsistency that we expect from the technical few: they say what benefits them, even if this is nonsense on his face, even if the reflection of the moment that he is clearly false. What is embarrassing is the record sheet that gives them a free judgment to do so.